Genentech’s $700M North Carolina build; Telix gets CRL for imaging agent news2025-08-28T15:04:01+00:00August 28th, 2025|Endpoints News|
REMS tweaks for Travere’s Filspari; AstraZeneca stops early-phase cardio studynews2025-08-28T14:48:02+00:00August 28th, 2025|Endpoints News|
Prothena reports Phase 1 Alzheimer’s data, noting high ARIA-E eventsnews2025-08-28T14:37:50+00:00August 28th, 2025|Endpoints News|
Stanford spinout Shenandoah Therapeutics raises $21.5M to turn cancer drivers against themselvesnews2025-08-28T14:00:36+00:00August 28th, 2025|Endpoints News|
Walgreens names new CEO and splits off businesses as take-private deal closesnews2025-08-28T13:48:43+00:00August 28th, 2025|Endpoints News|
Prasad explains why FDA revoked Pfizer’s Covid vaccine EUA for childrennews2025-08-28T13:10:59+00:00August 28th, 2025|Endpoints News|
ALIGNMT AI raises $6.5M to keep healthcare AI in checknews2025-08-28T13:00:36+00:00August 28th, 2025|Endpoints News|
Why Twin Health is betting on ‘digital twins’ to tackle obesitynews2025-08-28T13:00:18+00:00August 28th, 2025|Endpoints News|
FDA again rejects Outlook Therapeutics’ version of Avastin for wet AMDnews2025-08-28T11:55:50+00:00August 28th, 2025|Endpoints News|
Novo’s first obesity deal under new CEO is a $550M pact with RNA startup Replicatenews2025-08-28T11:00:46+00:00August 28th, 2025|Endpoints News|
